chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Client received the 1st dose of the COVID vaccine (Pfizer Lot #EW0187 expiration date 07/10/2021) at 1534. At 1552, the client's friend walked up to the EMT station and asked, "she's feeling dizzy, can we move her to the back chair?" EMT and PHN escorted the client to the zero gravity chair. The client stated, "I'm feeling a little hot, and dizzy. My heart is racing. I think it's just psychological." Client alert and oriented times four. Vital signs taken at 1552 (blood pressure 148/90, heart rate 75, oxygen 95%). Client stated, "I'm afraid of needles. I ate a little before right before coming to my appointment." Client denied SOB. Vital signs taken at 1602 (blood pressure 122/84, heart rate 69, oxygen 96%). At 1602, client stated, "I don't feel dizzy anymore." Vital signs taken at 1612 (blood pressure 122/84, heart rate 70, oxygen 96%). Client is allergic to Codeine, "and some foods." Client stated, "I'm missing some organs. I don't have my thyroid or spleen anymore." Client is currently taking Thyroxine. Vital signs taken at 1622 (blood pressure 130/86, heart rate 66, oxygen 96%). PHN provided education to the client on when to seek emergency services, and to follow up with her primary care provider. At 1623, client stated. "I feel fine," and left the facility unassisted with a steady gait.
This spontaneous report was received from a nurse on behalf of a physician and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 03-DEC-2018, the patient was inadvertently vaccinated with improperly stored dose of GARDASIL 9 (lot # R017133, expiration date: 29-APR-2021, dose and route of administration were not provided) for prophylaxis. No adverse effects were reported. Administered dose of GARDASIL 9 experienced temperature excursion of 60 Fahrenheit degrees for 4 days and 8 hours. There was previous temperature excursion between 47 to 77 Fahrenheit degrees (reported also as 50 Fahrenheit degrees) for 24 hours on 29-NOV-2018. Digital data logger was involved.
These symptoms persisted for 34 hours: 103 fever, body aches, muscle cramps, nausea, shaking, skin sensitivity. As of now, I am still experiencing fatigue, soreness, and 99.2 temp.
Left arm is red and tender to the touch.  Yesterday had a slight fever and said his head hurt.
Anaphylactic reactions happening every time she exercise/sweat.; high histamine levels; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 20-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 04Jan2022 at 15:00 as dose 3 (booster), single (Lot number: FJ1611) at the age of 20 years, in right arm for COVID-19 immunisation. The patient's relevant medical history included: "Exercise induced anaphylaxis" (unspecified if ongoing); "known allergies: fruits" (unspecified if ongoing); "Known allergies: Tree nuts" (unspecified if ongoing). There were no concomitant medications. The patient did not receive any other vaccines within four weeks or other medications within two weeks of the vaccination. Vaccination history included: BNT162b2 (dose 1; lot number: EW0172), administration date: 21May2021, when the patient was 19-years-old, for COVID-19 immunization; BNT162b2 (dose 2; lot number: EW0172), administration date: 06Jun2021, when the patient was 19-years-old, for COVID-19 immunization, reaction(s): "Hives on neck and chest". The following information was reported: On 27Jan2022 at 20:15, after the third dose, the patient had anaphylactic reactions happening every time she exercised or sweat. She had hives on neck and chest. She was diagnosed with high histamine levels and exercise induced allergy. She had uncontrollable anaphylactic reactions happening about once a month and continuing. The symptoms included itching all over her body, swollen face/feet, hives and redness all over the face, no airway through nostrils, coughing, wheezing, and trouble breathing. The events required an emergency room visit and were reported as life-threatening. The patient received treatment with an unspecified steroid. The clinical outcomes of the anaphylactic reactions and high histamine levels were recovered with sequelae on unknown dates in 2022.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201067858 same patient, different dose, different AE;
Client suddenly lost consciousness, falling face forward onto the tile.  She regained consciousness quickly, but was shaken up and tearful.  She had a large goose egg sized lump above her left eye.  Client was examined by our physician and was able to drive herself home after resting for approximately half an hour.
black and blue mark; tinnitus; Vaccination site warmth; itching; red, 3 to 3.5 inches in diameter circle lump; large lump at the injection site; only sleep on my right side; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE MASS (large lump at the injection site), INJECTION SITE DISCOLOURATION (black and blue mark), TINNITUS (tinnitus), SLEEP DISORDER (only sleep on my right side) and VACCINATION SITE WARMTH (Vaccination site warmth) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Heart disease, unspecified.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced SLEEP DISORDER (only sleep on my right side). On 17-Feb-2021, the patient experienced INJECTION SITE MASS (large lump at the injection site), TINNITUS (tinnitus), VACCINATION SITE WARMTH (Vaccination site warmth), INJECTION SITE PRURITUS (itching) and INJECTION SITE ERYTHEMA (red, 3 to 3.5 inches in diameter circle lump). On 28-Feb-2021, the patient experienced INJECTION SITE DISCOLOURATION (black and blue mark). On 28-Feb-2021, INJECTION SITE PRURITUS (itching) had resolved. At the time of the report, INJECTION SITE MASS (large lump at the injection site), INJECTION SITE DISCOLOURATION (black and blue mark), SLEEP DISORDER (only sleep on my right side) and INJECTION SITE ERYTHEMA (red, 3 to 3.5 inches in diameter circle lump) had not resolved, TINNITUS (tinnitus) had resolved and VACCINATION SITE WARMTH (Vaccination site warmth) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not reported by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 01-Mar-2021: No specific follow-up information recorded.
Information has been received from a healthcare worker via a company representative referring to a male patient of unknown age. The patient's concurrent condition and medical history were not reported. On unknown dates the patient was vaccinated with an unspecified number of doses of Hepatitis B vaccine (manufacturer unknown) (lot#, expiration date, dose and route were unknown). On an unknown date the patient had titers drawn which were negative. As a result, the patient was then administered another dose of an unspecified Hepatitis B vaccine (manufacturer unknown) (lot#, expiration date, dose and route were unknown) on an unspecified date. The patient then had titers drawn again on an unspecified date which were positive. Additional information is not expected as there was no consent for contacting the physician.
Local reactions back to back; This spontaneous case was received on 17-Dec-2020 from other non-health professional (consumer) via Med Communications (reference number: SEQW20-05827) and concerned a patient of unreported age and gender.  The patient's medical history and concomitant medications were not reported.  On an unspecified date, the patient was vaccinated with Flucelvax Quadrivalent (influenza vaccine, subunit influenza virus vaccine polyvalent; dose, route of administration and anatomical location: not reported) for influenza prophylaxis. The batch number reported was 279847, expiration date: 30-Jun-2021.  On an unspecified date, an unknown amount of time after receiving Flucelvax Quadrivalent, the patient developed local reactions back to back. It was not reported whether the patient received any corrective treatment.    The outcome of the event was unknown.  The reporter did not provide causality assessment.  The case is linked to the cases 202007727, 202007728 and 202007730 (the same reporter).  Company comment:The patient was vaccinated with the suspect product, Flucelvax Quadrivalent. On an unspecified date and unknown amount of time after receiving vaccine, the patient developed local reaction. Chronology is unclear. More information regarding temporal relationship, concomitant medications and underlying medical history is needed. Causality is assessed as unassessable due to lack of information.; Sender's Comments: The patient was vaccinated with the suspect product, Flucelvax Quadrivalent. On an unspecified date and unknown amount of time after receiving vaccine, the patient developed local reaction. Chronology is unclear. More information regarding temporal relationship, concomitant medications and underlying medical history is needed. Causality is assessed as unassessable due to lack of information.
Vaccine adm. at 1045 AM. Pt observed for 15 min with no s/sx adverse reaction. TC received from pt. at 230 pm stating 4-5 large pink hives on neck - itchy. (I) to take BENADRYL. Pt. reports will take it and that she has "sensitive skin". Will follow-up (I) if any s/sx, resp. difficulty to go to ER. 6/10/10 830PM. TC to patient. States BENADRYL worked earlier but still has areas that are "slightly pink". She is going to take 2 BENADRYL now and go to bed. Big blotches are completely gone. 6/11/10 2 PM. TC to patient. She said all areas have gone away completely. No pink areas or blotches remain. Denies ever having any respiratory difficulty or other complaints.
Patient came into the pharmacy about three weeks after vaccination to consult about his reaction he believes was due to the vaccine. Patient said he started to notice a reaction within the next couple of days of redness, discoloration, dry loose skin and peeling, scabbing, and severe itchiness all over his body. Patient is still having issues with his skin even within.
Mother reports-marked swelling entire left thigh - redness and heat-beginning 2-27-03 am-child afebute-tylenol given for inflammation-no restriction of ambulation-painful to touch-inflammationsubsiding-saw doctor on 2-28-03.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided. On 22-FEB-2016, the patient was vaccinated with the first dose of GARDASIL 9, injection, (dose, route of administration, injection site, lot number and expiration date were not reported). On 25-APR-2016, the patient received the second dose of GARDASIL 9, injection, (dose, route of administration, injection site, lot number and expiration date were not reported). The pharmacist stated that the third dose of GARDASIL 9, lot # M003659, expiration date: 20-SEP-2017, (dose, route of administration and injection site were not provided) was administered on 23-JUN-2016. No adverse reactions were reported. Additional information has been requested.
On the evening (8:00 pm) of my second COVID vaccination, I experienced severe ovulation pain. It was comparable to having a 15-20 minute contraction during unmedicated childbirth. It impaired my ability to function. I was bent over in pain and took a hot bath and two ibuprofen.  It subsided in about 30 minutes, but I continued to feel weak afterwards.   I was on cycle day 17 and my average cycle length is 28 days. I have a Paraguard IUD and do not take hormonal birth control.  I do experience mid cycle pain with some regularity, but this was by far my most severe experience.
Patient received the Pfizer vaccine on 1/25/21 and 2/15/21 so was fully vaccinated when they tested positive for COVID-19 on 9/23/21
Information has been received from a physician concerning a 24 week old male infant who on 19-JUN-2008 was vaccinated orally with a first dose of ROTATEQ (Oka/Merck). It was reported that the patient was inadvertently administered his first dose of 24 weeks old. There were no adverse effects reported. At the time of the report the patient's status was unknown. There was no product quality complaint involved. Additional information has been requested.
Aura type symptoms being seen an hour after vaccine administration (rainbow and geometrical shapes). Appearance in eyes as if I just looked into a bright light(unable to see certain areas of vision, such as half of someone's face, half a word..etc...). Aura has gone away. Vision loss improved by the next day, but is still there.  Arm still feels bruised and aches into shoulder 2 weeks later.   Some itching at site on and off.
Syncopal episode, pallor, lightheaded, immediately after shot given then vomiting. Was in office for 60 minutes until recovered.
high pitched screaming which started approx 2hr p/vax & lasted 3hr;rt thigh, hot, red, tender to touch;t101;seen by pediatrician;rx DPH, motrin & APAP
Had no side effects yesterday. This was my second dose. Tonight I noticed my arm felt a little itchy around where the shot was given. I had not removed the band-aid before tonight but when I did under; Red Rash; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 66-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection, Batch/Lot number and expiration dates were not reported), via an unspecified route of administration in right arm on 13Feb2021 at 14:00 (age at vaccination was 66 years non pregnant)) as dose 2, single for COVID-19 immunization. Medical history included, gastroesophageal reflux disease from an unknown date. Concomitant medication included rabeprazole sodium DR 20 MG (RABEPRAZOLE SODIUM), colecalciferol (VITAMIN D 3) and vitamins. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection, Batch/Lot number and expiration dates were not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not test COVID-19 positive prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. The patient had no known allergies. On 14Feb2021 at 22:00 after second dose same night the patient noticed her arm felt a little itchy around where the shot was given. She had not removed the Band-Aid before tonight but when she did under where the sticky wings of the Band-Aid were, there was a little raised red rash on both sides but just at the outline of the Band-Aid and not in the center where the white part was located on the Band-Aid. she removed the Band-Aid tonight, washed the area with warm water, it did not seem to itch now. No treatment was received for the event. The outcome of the events was unknown. Follow-up attempts completed. No further information expected.  Follow-up (21May2021): Follow-up attempts completed. No further information expected.
The very next day and for the next three days I had over 103 fever bodyaches nauseous fatigue for over a week and the arm I get the shot and did not feel better until a week later.
Exhaustion; massive headache; This is a spontaneous report received from a contactable reporter (Other HCP). The reporter is the patient.  A 36-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 22Mar2021 (Lot number: EP6955) at the age of 36 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "diabetes" (unspecified if ongoing); "high blood pressure" (unspecified if ongoing). Concomitant medication included: LISINOPRIL AND HYDROCHLORTIAZIDE; NUVARING; GAVISCON ES; PEPTID. The patient had no known allergy (NKA). was the patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since vaccination. The patient was vaccinated in other facility. The patient did not receive other vaccines within 4 weeks prior to the COVID vaccine. The following information was reported: FATIGUE (non-serious) with onset 22Mar2021, outcome "recovering", described as "Exhaustion"; HEADACHE (non-serious) with onset 22Mar2021, outcome "recovering", described as "massive headache". Therapeutic measures were not taken as a result of fatigue, headache.  No follow-up attempts are possible. No further information is expected.
I realized I noticed with dose #1 I developed Covid Arm. My arm was completely inflamed and swollen lymph nodes under my arm. The Covid arm faded 3 months later but was darker than the rest of my body. After dose #2, approximately a week later you noticed intense itching that would randomly appear, that was hot and inflamed. I was prescribed triamcinolone. I looked up my symptoms and feel that I have Chronic Idiopathic Urticaria. I have been treating it with 20mg Zyrtec and I have to take daily for relief.
Vaccine received on 01/22 - Following day, sore arm/ headache/ body aches/ chills/ fatigue - this resolved 01/24/2021. 02/04/2021, noticed a severe headache & numbness / tingling to left side of face, swollen lymph nodes, earache.
Faulty needle unable to penatrate skin.  a new syringe with new dose used and delivered.  So the faulty needle and syringe dose was unable to be used.
Hurt all over; Head would blow off and couldn't function; Feels weak/weak as a kitten; Can't get out of bed; Even her shoulders and neck are affected; She threw up; Head would blow off and couldn't function; Incontinent; This is a spontaneous report received from contactable reporter(s) (Other HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 11Oct2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Sepsis" (unspecified if ongoing), notes: Had sepsis a couple of months ago. There were no concomitant medications. Vaccination history included: Bnt162b2 ((1st dose) DOSE 1, SINGLE), for COVID-19 immunization, reaction(s): "was pooped"; Bnt162b2 ((2nd dose) DOSE 2, SINGLE), for COVID-19 immunization. The following information was reported: PAIN (non-serious) with onset Oct2021, outcome "unknown", described as "Hurt all over"; HEADACHE (non-serious), FEELING ABNORMAL (non-serious) all with onset Oct2021, outcome "unknown" and all described as "Head would blow off and couldn't function"; ASTHENIA (non-serious) with onset Oct2021, outcome "unknown", described as "Feels weak/weak as a kitten"; BEDRIDDEN (non-serious) with onset Oct2021, outcome "unknown", described as "Can't get out of bed"; MUSCULOSKELETAL DISCOMFORT (non-serious) with onset Oct2021, outcome "unknown", described as "Even her shoulders and neck are affected"; VOMITING (non-serious) with onset Oct2021, outcome "unknown", described as "She threw up"; INCONTINENCE (non-serious) with onset 2021, outcome "unknown", described as "Incontinent". Therapeutic measures were taken as a result of pain, headache, asthenia, bedridden, musculoskeletal discomfort, vomiting, feeling abnormal.  Additional information: Patient received the booster dose of the Pfizer COVID-19 vaccine on Monday 11Oct2021 and hurt all over, head would blow off and could not function. Patient further reported that she feels weak and can not get out of bed. She took Tylenol. Patient stated that even her shoulders and neck are affected, and mentioned that she threw up. Patient had sepsis a couple of months ago. Patient stated that her daughter works at a nursing home and would like to know if she could give her symptoms to her. After the first dose the patient was pooped. Then the second one did not bother the patient. Monday the patient got the booster shot and she hurt all over, she thought her head would blow off, and she could not function. The patient was feeling better then. This morning the patient went to the bathroom, she was inconstant, and was too tired to put the diaper back on so she curled back up in bed naked. The patient was weak as a kitten. The patient had sepsis a couple of months ago does that have anything to do with how she was feeling now.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I received the second dose of the shot on 08/21/21 at that time I was  5 weeks pregnant. On 08/30/21 I started experiencing cramping and a little spotting. I went to the doctor on 09/01/21 when I got to the doctor I had blood everywhere coming from me. I formed 3 blood clots and prior to receiving the 2nd shot I went to the doctor and nothing was wrong and everything as fine. Now I have cramping and on blood thinners and 2 more blood clots to pass and I believe it?s from the 2nd shot. I never experienced anything like this.
Acute hearing loss, tinnitus, and fullness in right ear occurring within 20 hours after vaccine
This vaccine was used after the BUD.  When we received this vaccine vaccine our nurse called State  or manufacture to confirm the expiration date, she was advised to use the date that was on the box.   This nurse is no longer with us.This patient has not had any adverse reaction after the vaccine that was reported to us.
Dizzy; shortness of breath; flushed; elevated heart rate; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 16 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 13May2021 13:00 (Lot number: ER8736) at the age of 16 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Preemie" (unspecified if ongoing), notes: (10 weeks early); "VCFS" (unspecified if ongoing); "clubfeet" (unspecified if ongoing); "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (product=COVID 19, lot number=ER8736, lot unknown=False, dose number=1), when the patient was 16 years old, for Covid-19 Immunisation. The following information was reported: DIZZINESS (non-serious) with onset 07Jun2021 14:30, outcome "not recovered", described as "Dizzy"; DYSPNOEA (non-serious) with onset 07Jun2021 14:30, outcome "not recovered", described as "shortness of breath"; FLUSHING (non-serious) with onset 07Jun2021 14:30, outcome "not recovered", described as "flushed"; HEART RATE INCREASED (non-serious) with onset 07Jun2021 14:30, outcome "not recovered", described as "elevated heart rate". Relevant laboratory tests and procedures are available in the appropriate section.  Follow-up attempts are completed. No further information is expected